Intelligent Ultrasound Group plc
("Intelligent Ultrasound" or the "Group")
Trading update
Intelligent Ultrasound Group plc (AIM: MED), the artificial intelligence (AI) based ultrasound software and simulation company, announces that Group turnover for the six months to 30 June 2019, which is currently generated entirely by the Group's Simulation Division, is expected to grow by 25% to approximately £3.1m (H1 2018: £2.5m). Cash at bank at 30 June 2019 was £3.5m (31 December 2018: £5.6m).
The full Half-Year Report is expected to be released in late July.
Stuart Gall, CEO of Intelligent Ultrasound Group plc, commented: "Following on from our Clinical Division's milestone AI contract win which we announced on 4 July 2019, it is particularly pleasing to be able to report continued growth in the first half of the year by our Simulation Division, bringing it closer to breakeven and underpinning our confidence in achieving management's expectations for the full year."
Enquiries:
Intelligent Ultrasound Group plc |
||||
Stuart Gall, CEO |
Tel: +44 (0)29 2075 6534 |
|||
|
|
|||
Cenkos Securities - Nominated Advisor and broker |
Tel: +44 (0)20 7397 8900 |
|||
Giles Balleny / Cameron MacRitchie (Corporate Finance) |
|
|||
Michael Johnson / Julian Morse (Sales) |
|
|||
|
|
|||
Walbrook PR |
Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com |
|||
Anna Dunphy / Paul McManus |
Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893 |
|||